MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    The usefulness of 18 F-DOPA PET scan in diagnostically challenging patients at a movement disorder clinic

    M. Khider, A. Dorutyer, J. Warwick, J. Carr (Cape Town, South Africa)

    Objective: The aim of this study was to determine the usefulness of 18 F-DOPA PET scan in diagnostically challenging patients at our movement disorder clinic…
  • 2018 International Congress

    Changes in cortical thickness in patients with early Parkinson’s disease at different Hoehn and Yahr stages

    Y. Gao, K. Nie, M. Mei, M. Guo, Z. Huang, L. Wang, J. Zhao, B. Huang, Y. Zhang, L. Wang (Guangzhou, China)

    Objective: This study was designed to explore changes in cortical thickness in patients with early Parkinson's disease (PD) at different Hoehn and Yahr (H-Y) stages…
  • 2018 International Congress

    The effect of age on Substantia Nigra Hyperechogenicity in PD patients and healthy controls

    T. Toomsoo, A-H. Pool, I. Liepelt–Scarfone, L. Kadastik-Eerme, I. Rubanovits, T. Asser, D. Berg, P. Taba (Tallinn, Estonia)

    Objective: To analyze whether the size of SN+ is differentially affected depending on disease start side. Secondly to analyze the interaction between a range of…
  • 2018 International Congress

    Alteration to Basal Ganglia Morphology in Freezing of Gait in Parkinson’s Disease

    N. D'Cruz, G. Vervoort, W. Vandenberghe, A. Nieuwboer (Leuven, Belgium)

    Objective: To characterize the subcortical grey matter adaptations related to Freezing of Gait in Parkinson’s Disease (PD). Background: Owing to its connections with motor, cognitive…
  • 2018 International Congress

    Feasibility aspects of evaluating neuroplastic changes after balance training in Parkinson´s disease: A pilot randomised controlled trial

    H. Johansson, M. Hagströmer, U. Ekman, B. Leavy, M. Freidle, E. Schalling, P. Svenningsson, E. Franzén (Huddinge, Sweden)

    Objective: The aim of this pilot study was to explore trial design and to assess feasibility and acceptability of the data collection methods and the…
  • 2018 International Congress

    Pallidal beta bursts in Parkinson’s disease and Dystonia

    R. Lofredi, WJ. Neumann, C. Brücke, J. Huebl, GH. Schneider, A. Kühn (Berlin, Germany)

    Objective: The aim of this study is to test whether prolonged beta burst duration is disease-specific for Parkinson's disease when compared to oscillatory activity in…
  • 2018 International Congress

    The Gut Microbiota in a Canadian Parkinson’s Disease Cohort

    M. Cirstea, E. Golz, B. MacVicar, B. Finlay, S. Cresswell (Vancouver, BC, Canada)

    Objective: To compare the gut microbiota between PD patients and matched controls in a Canadian cohort and to examine correlations between microbes and disease parameters…
  • 2018 International Congress

    Distinct effects of apathy and dopamine on effort-based decision making in Parkinson’s disease

    C. Le Heron, O. Plant, S. Manohar, Y. Ang, M. Jackson, G. Lennox, M. Hu, M. Husain (Oxford, United Kingdom)

    Objective: To determine if disrupted effort-based decision making (EBDM) underlies the syndrome of apathy in PD, and whether this disruption is modulated by the dopaminergic…
  • 2018 International Congress

    The Effect of Sleep Deprivation on Short-Term Memory and Emotion of Rotenone Treated Zebrafish Model of Parkinson Disease

    Y. Xiong, D. Lv, S. Wei, F. Wang, C. Liu (Suzhou, China)

    Objective: We investigated the long-term consequences of sleep deprivation on short-term memory and emotion using a rotenone treated zebrafish model of Parkinson disease. Background: Parkinson…
  • 2018 International Congress

    Non-motor outcomes of subthalamic DBS in PD depend on the location of volume of activated tissue

    JN. Petry-Schmelzer, H. Dafsari, M. Krause, T. Dembek, A. Keyoumars, A. Rizos, M. Silverdale, J. Evans, M. Barbe, G. Fink, P. Martinez-Martin, V. Visser-Vandewalle, A. Antonini, L. Timmermann, K. Ray-Chaudhuri (Cologne, Germany)

    Objective: To investigate the impact of stimulation location on non-motor symptoms (NMS) in PD patients with DBS in the subthalamic nucleus (STN) via an analysis…
  • « Previous Page
  • 1
  • …
  • 147
  • 148
  • 149
  • 150
  • 151
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley